Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review

被引：42
作者：
Blayney, Douglas W. [1 ,3 ]
Schwartzberg, Lee [2 ]
机构：
[1] Stanford Canc Inst, Stanford, CA 75216 USA
[2] Univ Nevada, Renown Inst Canc, Reno, NV USA
[3] 875 Blake Wilbur Dr,Room CC-2219,M-C 6576, Stanford, CA 94305 USA
来源：
CANCER TREATMENT REVIEWS | 2022年 / 109卷
关键词：
Chemotherapy -induced neutropenia; G-CSF; Trilaciclib; Plinablin; Efbemalenograstim alpha; Eflapegrastim; INDUCED FEBRILE NEUTROPENIA; COLONY-STIMULATING FACTOR; RELATIVE DOSE INTENSITY; PER-CYCLE PEGFILGRASTIM; US CLINICAL-PRACTICE; BREAST-CANCER; PRIMARY PROPHYLAXIS; PLINABULIN PLIN; BIOSIMILAR FILGRASTIM; RECEIVING CHOP;
D O I：
10.1016/j.ctrv.2022.102427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：10
相关论文
共 105 条
[1]   2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours [J].
Aapro, M. S. ;
Bohlius, J. ;
Cameron, D. A. ;
Dal Lago, Lissandra ;
Donnelly, J. Peter ;
Kearney, N. ;
Lyman, G. H. ;
Pettengell, R. ;
Tjan-Heijnen, V. C. ;
Walewski, J. ;
Weber, Damien C. ;
Zielinski, C. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (01) :8-32
[2]  
Aapro Matti, 2012, J Oncol Pharm Pract, V18, P171, DOI 10.1177/1078155211407367
[3]  
[Anonymous], NEUL CONTR TRIAL F 6
[4]  
[Anonymous], Drug Approval Package: Gabitril (Tiagabine)
[5]  
[Anonymous], COSELA TRILACICLIB P
[6]  
[Anonymous], Prevention and treatment of cancer related infections. Version I.2013
[7]   Risk of chemotherapy-induced febrile neutropenia in patients with metastatic cancer not receiving granulocyte colony-stimulating factor prophylaxis in US clinical practice [J].
Averin, Ahuva ;
Silvia, Amanda ;
Lamerato, Lois ;
Richert-Boe, Kathryn ;
Kaur, Manpreet ;
Sundaresan, Devi ;
Shah, Neel ;
Hatfield, Mark ;
Lawrence, Tatiana ;
Lyman, Gary H. ;
Weycker, Derek .
SUPPORTIVE CARE IN CANCER, 2021, 29 (04) :2179-2186
[8]  
Awad Mina, 2017, P T, V42, P19
[9]   G-CSF utilization rate and prescribing patterns in United States: associations between physician and patient factors and GCSF use [J].
Barnes, Gisoo ;
Pathak, Ashutosh ;
Schwartzberg, Lee .
CANCER MEDICINE, 2014, 3 (06) :1477-1484
[10]   Eflapegrastim's enhancement of efficacy compared with pegfilgrastim in neutropenic rats supports potential for same-day dosing [J].
Barrett, John A. ;
Choi, Jaehyuk ;
Lakshmikanthan, Sribalaji ;
Kim, Yu-Yon ;
Greene, Douglas ;
Kolli, Prasad ;
Song, Tae Hun ;
Choi, In Young ;
Kim, Young Hoon ;
Lebel, Francois .
EXPERIMENTAL HEMATOLOGY, 2020, 92 :51-61
12345678910